- Home
- TAIT vs BCTX Comparison
TAIT vs BCTX Comparison
Compare TAIT & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAIT
- BCTX
- Stock Information
- Founded
- TAIT 1989
- BCTX 2014
- Country
- TAIT United States
- BCTX Canada
- Employees
- TAIT N/A
- BCTX N/A
- Industry
- TAIT Electronic Components
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- TAIT Technology
- BCTX Health Care
- Exchange
- TAIT Nasdaq
- BCTX Nasdaq
- Market Cap
- TAIT 12.8M
- BCTX 14.4M
- IPO Year
- TAIT 1995
- BCTX N/A
- Fundamental
- Price
- TAIT $2.14
- BCTX $7.87
- Analyst Decision
- TAIT
- BCTX Strong Buy
- Analyst Count
- TAIT 0
- BCTX 1
- Target Price
- TAIT N/A
- BCTX $40.00
- AVG Volume (30 Days)
- TAIT 12.8K
- BCTX 89.2K
- Earning Date
- TAIT 08-14-2025
- BCTX 10-28-2025
- Dividend Yield
- TAIT 9.37%
- BCTX N/A
- EPS Growth
- TAIT N/A
- BCTX N/A
- EPS
- TAIT N/A
- BCTX N/A
- Revenue
- TAIT $4,203,000.00
- BCTX N/A
- Revenue This Year
- TAIT N/A
- BCTX N/A
- Revenue Next Year
- TAIT N/A
- BCTX N/A
- P/E Ratio
- TAIT N/A
- BCTX N/A
- Revenue Growth
- TAIT N/A
- BCTX N/A
- 52 Week Low
- TAIT $2.01
- BCTX $6.00
- 52 Week High
- TAIT $3.05
- BCTX $294.00
- Technical
- Relative Strength Index (RSI)
- TAIT 53.36
- BCTX 42.07
- Support Level
- TAIT $2.07
- BCTX $7.28
- Resistance Level
- TAIT $2.17
- BCTX $8.82
- Average True Range (ATR)
- TAIT 0.04
- BCTX 0.74
- MACD
- TAIT 0.01
- BCTX 0.54
- Stochastic Oscillator
- TAIT 78.12
- BCTX 66.13
About TAIT Taitron Components Incorporated
Taitron Components Inc is a supplier of originally designed and manufactured (ODM) products that include value-added engineering and turn-key solutions. It focuses on providing original equipment manufacturers (OEMs) and contracts electronic manufacturers (CEMs) with ODM products for their multi-year turn-key projects and ODM electronic components. The company's product offerings range from discrete semiconductors to small electronic devices. The company also distributes brand-name electronic components with a vast inventory available on hand. Its Taiwan and China locations, provide support for inventory sourcing, purchases, and coordinating the manufacture of ODM Projects and ODM Components.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.